Cholesterol and vitamins: Revisited study

Journal of Biological Regulators and Homeostatic Agents

Volumn 25, Issue 4, 2011, Pages 505-515

  Saggini, Andrea ^a   Anogeianaki, A ^b   Angelucci, D ^c   Cianchetti, E ^d   D'Alessandro, M ^e   Maccauro, G ^f   Salini, V ^c   Caraffa, A ^g   Tete S ^c   Conti, F ^e   Tripodi, D ^c   Fulcheri, M ^c   Frydas, S ^b   Shaik Dasthagirisaheb, Y B ^h  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF CHIETI   (Italy)

^d Ortona Hospital   (Italy)

^e SPIRITO SANTO HOSPITAL   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

^g UNIVERSITY OF PERUGIA   (Italy)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cholesterol; Inflammation; LDL; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; SATURATED FATTY ACID; SIMVASTATIN; TORCETRAPIB; TRIACYLGLYCEROL; VITAMIN;

ARTERY WALL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DECREASED APPETITE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; FLUSHING; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; LIVER TOXICITY; NAUSEA; NONHUMAN; PELLAGRA; REVIEW; RISK REDUCTION; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; ULCERATIVE COLITIS; VASODILATATION;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NIACIN; VITAMIN E; VITAMINS;

EID: 84855984277     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. IMPACT Study Group, M. Rubenfire, Safety and compliance with once-daily niacin extended-release/ Iovastatin as Initial Therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) Study. Am J Cardiol 2004; 94:306-11.
2. Goldberg A, Alagona P, Capuzzi DM, et al. Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia. Am J Cardiol 2000; 85:1100-5. (Pubitemid 30214256)
3. Diabetes Multicenter Research Group, Grundy SM, Vega GL, McGovern ME, et al. Efficacy, safety, and tolerability of once daily niacin for the treatment of dyslipidemia associated with type 2 diabetes. Arch Intern Med 2002; 162:1568-76.
4. Profumo E, Buttari B, Alessandri C, Conti F, Capoano R, Valesini G, Salvati B, Riganò R. Beta2-glycoprotein I is a target of T cell reactivity in patients with advanced carotid atherosclerotic plaques. Int J Immunopathol Pharmacol 2010; 23:73-80.
5. Hossein-Nezhad A, Mirzaei K, Birami Jamal F, Mirfakhraei R, Sedighi N. Variation in the COX-2 gene may modify the effect of alendronate on vertebral fracture prevention. Eur J Inflamm 2010; 8:143-49.
6. Sharma JN. Activation of the bradykinin system by angiotensin-converting enzyme inhibitors. Eur J Inflamm 2010; 8:55-61
7. Calabrò P, Riegler L, Limongelli G, et al. Production of serum amyloid A in response to inflammatory cytokines by human adipocytes. Eur J Inflamm 2010; 8:99-105.
8. Aureli A, Del Beato T, Sebastiani P, Marimpietri A, Melillo CV, Sechi E, Di Loreto S. Attention-deficit hyperactivity disorder and intellectual disability: a study of association with brain-derived neurotrophic factor gene polymorphisms. Int J Immunopathol Pharmacol 2010; 23:873-80.
9. Kamanna VS, Ganji SH, Kashyap ML. Niacin: an old drug rejuvenated. Curr Atheroscler Rep 2009; 11(1):45-51.
10. Ursini F, Succurro E, Grembiale A, Rudi S, Grembiale RD, Arturi F. Sudden progression from impaired glucose tolerance to type 2 diabetes after discontinuation of administration of anti-tumor necrosis factor-alpha antibody infliximab. Int J Immunopathol Pharmacol 2010; 23:961-63.
11. Benyó Z, Gille A, Kero J, Csiky M, Suchánková MC, Nüsing RM, Moers A, Pfeffer K, Offermanns S. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 2005; 115:3634-40. (Pubitemid 43121852)
12. Tavazzi E, Bargiggia V, Pichiecchio A, et al. HIV-related acute inflammatory leukoencephalopathy of undetermined origin: review of the literature. Int J Immunopathol Pharmacol 2010; 23:693-700.
13. Woodburn KW, Schatz PJ, Fong K-L, Beaumier P. Erythropoiesis equivalence, pharmacokinetics and immune response following repeat Hematide™ administration in cynomolgus monkeys. Int J Immunopathol Pharmacol 2010; 23:121-29.
14. Brown GB, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345:1583-92. (Pubitemid 33126837)
15. Rajavashisth TB, Andalibi A, Territo MC, et al. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature (Lond) 1990; 344:254-57.
16. Richardson VJ. Divergent and synergistic regulation of matrix metalloprotease production by cytokines in combination with C-C chemokines. Int J Immunopathol Pharmacol 2010; 23:715-26.
17. Hervier B, Rimbert M, Maisonneuve H, Hamidou MA. Large granular lymphocyte leukemia with pure red cell aplasia associated with autoimmune poly endocrinopathycandidiasis-ectodermal dystrophy: an unfortuitous association? Int J Immunopathol Pharmacol 2010; 23:947-950.
18. Falcone C, Buzzi MP, D'Angelo A, et al. Apelin plasma levels predict arrhythmia recurrence in patients with persistent atrial fibrillation. Int J Immunopathol Pharmacol 2010; 23:917-925.
19. Balistreri CR, Li Vecchi M, Iatrino R, Caruso M, Incalcaterra E, Caruso C, Candore G. Chronic kidney disease and inflammation: role of +896A/G of pro-inflammatory polymorphism of TLR4 gene and Δ32 deletion of CCR5 gene. Eur J Inflamm 2010; 8:191-194.
20. Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992; 140:301-16.
21. Shekhawat N, Vijayvergia R. Investigation of anti-inflammatory, analgesic and antipyretic properties of Madhuca indica Gmel. Eur J Inflamm 2010; 8:165-71.
22. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature (Lond) 1998; 394:894-97. (Pubitemid 28410911)
23. Imai H, Sunaga N, Shimizu Y, et al. Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer. Int J Immunopathol Pharmacol 2010; 23:153-64.
24. Guerranti R, Bertocci E, Fioravanti A, Papakostas P, Montella A, Guidelli GM, Cortelazzo A, Nuti R, Giordano N. Serum proteome of patients with systemic sclerosis: molecular analysis of expression and prevalence of haptoglobin alpha chain isoforms. Int J Immunopathol Pharmacol 2010; 23:901-9.
25. Amorino GP, Hoover RL. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am J Pathol 1998; 152:199-207. (Pubitemid 28028060)
26. Shaik-Dasthagirisaheb YB, Castellani ML, Tripodi D, et al. PGD2, IL-1-family members and mast cells. Eur J Inflamm 2010; 8:137-42.
27. Cantarini L, Rigante D, Lucherini OM, et al. Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature. Int J Immunopathol Pharmacol 2010; 23:701-7.
28. Di Lorenzo G, Imbimbo M, Leopardo D, Marciano R, Federico P, Buonerba C, Salvatore B, Marinelli A, Calmieri G. A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient. Int J Immunopathol Pharmacol 2010; 23:951-54.
29. Robertson AK, Hansson GK. T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol 2006; 26:2421-32. (Pubitemid 44607461)
30. Fotio AL, Olleros ML, Vesin D, et al. In vitro inhibition of lipopolysaccharide and Mycobacterium bovis Bacillus Calmette Guérin-induced inflammatory cytokines and in vivo protection from D-alactosamine/LPS-mediated liver injury by the medicinal plant Sclerocarya birrea. Int J Immunopathol Pharmacol 2010; 23:61-72.
31. Migliore A, Padalino C, Massafra U, et al. Intra-articular injections of infliximab in the treatment of inflammatory rheumatic diseases: case reports and review of literature. Eur J Inflamm 2010; 8:49-54.
32. Postiglione L, Montuori N, Riccio A, Di Spigna G, Salzano S, Rossi G, Ragno P. The plasminogen activator system in fibroblasts from systemic sclerosis. Int J Immunopathol Pharmacol 2010; 23:891-900.
33. Graham ES, Angel CE, Schwarcz LE, Dunbar PR, Glass M. Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry. Int J Immunopathol Pharmacol 2010; 23:25-34.
34. Mason DP, Kenagy RD, Hasenstab D, et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 1999; 85:1179-85. (Pubitemid 30430623)
35. Sadeghi Koupaei MT, Ahangari G, Samanguiei Sh. Inflammatory mediator serotonin receptor gene (5-HTR3A) expression changes on human peripheral blood lymphocytes in rheumatoid arthritis. Eur J Inflamm 2010; 8:83-88.
36. Pietropaoli D, Tatone C, D'Alessandro AM, Monaco A. Possible involvement of advanced glycation end products in periodontal diseases. Int J Immunopathol Pharmacol 2010; 23:683-91.
37. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86:515-81.
38. Gelardi M, Cassano M, Cassano P, et al. Survival time of nasal mucous membrane ciliated cells: a preliminary study of cytological examination by phase-contrast microscopy. Eur J Inflamm 2010; 8:37-41.
39. Palumbo P, Melchiorre E, La Torre C, et al. Effects of phosphatidylcholine and sodium deoxycholate on human primary adipocytes and fresh human adipose tissue. Int J Immunopathol Pharmacol 2010; 23:481-89.
40. Bocchino M, Matarese A, Bellofiore B, Giacomelli P, Russo A, Signoriello G, Galati D, Sanduzzi A. Usefulness of IFN-gamma release assays in clinical management of difficult TB cases:evidence from clinical practice. Eur J Inflamm 2010; 8:43-47.
41. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002; 195:245-57. (Pubitemid 34461268)
42. Esposito M, Giunta A, Mazzotta A, Babino G, Talamonti M, Chimenti MS, Chimenti S. Continuous treatment of plaque-type psoriasis with etanercept: an observational long-term experience. Int J Immunopathol Pharmacol 2010; 23:503-9.
43. Navarro-González J, Mora-Fernández C, Gómez- Chinchón M, Muros M, Herrera H, Garcia J. Serum and gene expression profile of tumor necrosis factor-α and interleukin-6 in hypertensive diabetic patients: effect of amlodipine administration. Int J Immunopathol Pharmacol 2010; 23:51-59.
44. Meng X, Tancharoen S, Kawahara K-I, Nawa Y, Taniguchi S, Hashiguchi T, Maruyama I. 1,5-anhydroglucitol attenuates cytokine release and protects mice with type 2 diabetes from inflammatory reactions. Int J Immunopathol Pharmacol 2010; 23:105-19.
45. Chen Y-Z, Liu G, Senju S, et al. Identification of SARS-CoV spike protein-derived and HLA-A2-restricted human CTL epitope by using a new muramyl dipeptide-derivative adjuvant. Int J Immunopathol Pharmacol 2010; 23:165-77.
46. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995; 92:3893-97.
47. Brazzelli V, Grasso V, Fornara L, Moggio E, Gamba G, Villani S, Borroni G. Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity. Int J Immunopathol Pharmacol 2010; 23: Int J Immunopathol Pharmacol 2010; 23:911-16.
48. Nenna R, Tromba V, Berardi R, De Angelis D, Papoff P, Sabbatino G, Moretti C, Midulla F. Recombinant human deoxyribonuclease treatment in hospital management of infants with moderate-severe bronchiolitis. Eur J Inflamm 2010; 8:169-174.
49. Blankenberg S, Luc G, Ducimetiere P, et al. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003; 108:2453-59. (Pubitemid 37444405)
50. Pedram A, Razandi M, Hu RM, Levin ER. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem 1997; 272:17097-103. (Pubitemid 27289818)
51. Symeonidou I, Kourelis A, Frydas I, Karagouni E, Anogeianaki A, Hatzistilianou M, Frydas S. Modulation of NF-KB signalling pathways by parasites. J Biol Regul Homeost Agents 2010; 24:471-79
52. Borrelli I, Loffredo S, Staiano RI, Frattini A, Bergamaschi A, Marone G, Triggiani M. Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils. Int J Immunopathol Pharmacol 2010; 23:737-44.
53. Shimizu Y, Dobashi K, Endou K, et al. Decreased interstitial FOXP3+ lymphocytes in usual interstitial pneumonia with discrepancy of CXCL12/CXCR4 axis. Int J Immunopathol Pharmacol 2010; 23:449-61.
54. Cybulsky MI, Gimbrone MA, Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (Wash DC) 1991; 251:788-91.
55. Preetha SP, Devaraj H. Role of sulphated polysaccharides from Sargassum wightii in the control of diet-induced hyperlipidemia and associated inflammatory complications in rats. Eur J Inflamm 2010; 8:23-30.
56. Li H, Cybulsky MI, Gimbrone MA, Jr, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993; 13:197-204. (Pubitemid 23056792)
57. Fernandez TD, Torres MJ, Lopez S, Antunez C, Gomez E, Del Prado MF, Canto G, Bianca M, Mayorga C. Role of effector cells (CCR7-CD27) and effector-memory cells (CCR7-CD27+) in drug-induced maculopapular exanthema. Int J Immunopathol Pharmacol 2010; 23:437-47.
58. Gallelli L, Pelaia G, Fratto D, et al. Effects of budesonide on P38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells. Int J Immunopathol Pharmacol 2010; 23:471-79.
59. Blankenberg S, Tiret L, Bickel C, et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106:24-30. (Pubitemid 34747437)
60. Kureishi Y, Luo Z, Shoijima I, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000; 6:1004-10.
61. Pham TNQ, Rahman P, Richardson VJ. Divergent effects of infliximab and anakinra therapies on macrophage phenotype from patients with refractory rheumatoid arthritis. Int J Immunopathol Pharmacol 2010; 23:491-501.
62. Colella G, Cannavale R, Vicidomini A, Rinaldi G, Compilato D, Campisi G. Efficacy of a spray compound containing a pool of collagen precursor synthetic aminoacids (L-proline, L-leucine, L-lysine and glycine) combined with sodium hyaluronate to manage chemo/radiotherapy-induced oral mucositis: preliminary data of an open clinical trial. Int J Immunopathol Pharmacol 2010; 23:143-51.
63. Raines EW, Ferri N. Thematic review series: the immune system and atherogenesis, cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res 2005; 46:1081-92. (Pubitemid 43109823)
64. Calabrò P, Riegler L, Limongelli G, et al. Production of serum amyloid A in response to inflammatory cytokines by human adipocytes. Eur J Inflamm 2010; 8:99-105.
65. Galliera E, Locati M, Mantovani A, Corsi MM. Chemokine system: new inflammatory markers on the horizon. Eur J Inflamm 2010; 8:1-6.
66. Brown BG, Cheung MC, Lee AC, Zhao X-Q, Chait A. Antioxidant Vitamins and Lipid Therapy: End of a Long Romance? Arteriosclerosis, Thrombosis, and Vascular Biology: J Am Heart Ass 2002; 22:1535-46.
67. Castellani ML, Anogeianaki A, Toniato E, et al. Interrelationship between chemokines and mast cells. Eur J Inflamm 2010; 8:7-14.
68. Ciprandi G, Fenoglio D, Ferrera F, De Amici M, Marseglia G. ELISPOT and ELISA assessment of interferon-gamma after sublingual immunotherapy. Eur J Inflamm 2010; 8:31-35.
69. Shekhawat N, Vijayvergia R. Investigation of anti-inflammatory, analgesic and antipyretic properties of Madhuca indica Gmel. Eur J Inflamm 2010; 8:165-71.
70. Sharma JN. Activation of the bradykinin system by angiotensin-converting enzyme inhibitors. Eur J Inflamm 2010; 8:55-61
71. Palinski W, Miller E, Witztum JI. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA 1995; 92:821-25.
72. Vogel T, Wolters HH, Hölzen J, Schmidt HH, August C, Dahrenmöller C, Senninger N, Brockmann JG. Rituximab rescue therapy for refractory early acute rejection after liver transplantation. Eur J Inflamm 2010; 8:125-29.
73. Zhang G-H, Liu Y-F, Hu H-Y. Preparation and cytotoxicity effect of anti-hepatocellular carcinoma SCFV immunoliposome on hepatocarcinoma cell in vitro. Eur J Inflamm 2010; 8:75-82
74. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320:915-24. (Pubitemid 19101597)
75. Esposito G, Rossi F, Puca A, Albanese A, Sabatino G, Matteini P, Lofrese G, Maira G, Pini R. An experimental study on minimally occlusive laser-assisted vascular anastomosis in bypass surgery: the importance of temperature monitoring during laser welding procedures. J Biol Regul Homeost Agents 2010; 24:307-15.
76. Li Q, Kobayashi M, Inagaki H, et al. A day trip to a forest park increases human natural killer activity and the expression of anti-cancer proteins in male subjects. J Biol Regul Homeost Agents 2010; 24:157-65.
77. Rosenson RS, Tangney CC, Casey LC. Inhibition of proinflammatory cytokine production by pravastatin, Lancet 1999; 353:983-84. (Pubitemid 29132615)
78. Singh SS, Yadav SK, Haldar C. Effect of glucocorticoid and melatonin on immune function of an Indian tropical bird, Perdicula Asiatica: an in vivo and in vitro study. Eur J Inflamm 2010; 8:89-97.
79. Papakonstantinou P, Tziris N, Kapoukranidou D, Gotzamani-Psarrakou A, Tsonidis CHR, Patsikas MN, Papazoglou G. The effect of porcine Orexin A on glucose-dependent insulinotropic polypeptide plasma concentrations in pigs. Eur J Inflamm 2010; 8:15-21.
80. Ciccocioppo R, Finamore A, Mengheri E, et al. Isolation and characterization of circulating tissue transglutaminase-specific t cells in coeliac disease. Int J Immunopathol Pharmacol 2010; 23:179-91.
81. Sun W-Z, Chang M-C, Hsiao P-N, Chen C-A, Hsu Y-T, Hsieh C-Y, Cheng W-F. Morphine-sparing effect by COX-1 inhibitor sustains analgesic function without compromising antigen-specific immunity and anti-tumor effect of naked DNA vaccine. Int J Immunopathol Pharmacol 2010; 23:91-104.
82. Superko HR, King S. Lipid management to reduce cardiovascular risk: a new strategy is required. Circulation 2008; 117:560-68.
83. Matsuzaki S, Shimizu Y, Dobashi K, et al. Analysis on the co-localization of asbestos bodies and Fas or CD163 expression in asbestos lung tissue by in-air micro-PIXE. Int J Immunopathol Pharmacol 2010; 23:1-11.
84. Buhé V, Loisel S, Pers JO, Le Ster K, Berthou C, Youinou P. Updating the physiology, exploration and disease relevance of complement factor H. Int J Immunopathol Pharmacol 2010; 23:397-404.
85. Trikaliotis C, Soulountsi V, Tsorlini H, et al. Epidemiological study and classification of ICU infections, using the carrier state criterion. Eur J Inflamm 2010; 8:181-88.
86. Amanti A, Potalivo G, Pelosi F, Rende R, Cerulli G. Randomized prospective study on the use of Eufiss in the prevention of infections in patients treated with external fixation. Eur J Inflamm 2010; 8:189--92.
87. Muller DPR, Lloyd J, Wolff OH. Vitamin E and neurological function. Lancet 1983; 321:225-28.
88. Ciprandi G, De Amici M, Tosca MA, Marseglia G. Immunoglobulin production pattern in allergic and non-allergic subjects. Eur J Inflamm 2010; 8:193-99.
89. Neri G, Citraro L, Martinotti S, Toniato E, Castriotta A, De Rosa M, Filograna Pignatelli G. The role of atypical microorganisms in chronic oropharyngeal phlogosis. Eur J Inflamm 2010; 8:201-10.
90. Contasta I, Totaro R, Berghella A-M, Pellegrini P, Del Beato T, Carolei A, Adorno D. Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNβ1a treatment in multiple sclerosis patients. Int J Immunopathol Pharmacol 2010; 23:213-26.
91. Rubenfire M, Brook RD, Rosenson RS. Treating Mixed Hyperlipidemia and the Atherogenic LipidPhenotype for Prevention of Cardiovascular Events. Am J Med 2010; 123:892-898.
92. Sancini A, Caciari T, Andreozzi G, et al. Respiratory parameters in traffic policemen exposed to urban pollution. Eur J Inflamm 2010; 8:157-63.
93. Sirotkin AV, Chrenek P, Pivko J, Balazi A, Makarevich AV. Phosphodiesterase inhibitor 3-isobutyl-l-methylxanthine affects ovarian morphology and stimulates reproduction in rabbits. Eur J Inflamm 2010; 8:173-79.
94. Sainz J, Salas-Alvarado I, López-Fernández E, Oet al. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis. Int J Immunopathol Pharmacol 2010; 23:423-36.
95. Buonomo A, Altomonte G, De Pasquale T, et al. Allergic and non-allergic drug hypersensitivity reactions in children. Int J Immunopathol Pharmacol 2010; 23:881-90.
96. Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986; 8:1245-55. (Pubitemid 17208898)
97. Canner PL, Furberg CD, McGovern ME. Benefits of niacin in patients with versus without the metabolic syndrome and healed myocardial infarction (from the Coronary Drug Project). Am J Cardiol 2006; 97: 477-79. (Pubitemid 43190034)
98. Rosenson RS. Antiatherothrombotic effects of nicotinic acid. Atherosclerosis 2003; 171:87-96. (Pubitemid 37464633)
99. The Heart Protection Study Investigators, MRC/ BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:7-22.
100. Smith SC, Allen J, Blair S, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2006; 47:2130-39. (Pubitemid 44275145)
101. Bobryshev YV, Lord RS. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res 1998; 37:799-810. (Pubitemid 28231176)
102. Vanderlocht J, van Elssen CHMJ, Senden-Gijsbers BLMG, Meek B, Cloosen S, Libon C, Bos GMJ, Germeraad WTV. Increased tumor-specific CD8+ T cell induction by dendritic cells matured with a clinical grade TLR-agonist in combination with IFN-γ. Int J Immunopathol Pharmacol 2010; 23:35-50.
103. Marogna M, Colombo F, Cerra C, Bruno M, Massolo A, Canonica GW, Falagiani P, Passalacqua G. The clinical efficacy of a sublingual monomeric allergoid at different maintenance doses: a randomized controlled trial. Int J Immunopathol Pharmacol 2010; 23:937-45.
104. Bellizzi A, Barucca V, Di Nardo G, et al. JC viral reactivation in a pediatric patient with Crohn's disease. Int J Immunopathol Pharmacol 2010; 23:955-59.
105. Chiesa C, Pacifico L, Anania C, Poggiogalle E, Chiarelli F, Osborn JF. Helicobacter pylori therapy in children: overview and challenges. Int J Immunopathol Pharmacol 2010; 23:405-16.
106. Yilmaz A, Reiss C, Tantawi O, et al. HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. Atherosclerosis 2004; 172:85-93. (Pubitemid 38058605)
107. .Delli Pizzi S, Mantini D, Ferretti A, Caulo M, Salerio I, Romani GL, Del Gratta C, Tartaro A. Pharmacological functional MRI assessment of the effect of ibuprofenarginine in painful conditions. Int J Immunopathol Pharmacol 2010; 23:927-35.
108. Sancini A, Tomei F, Schifano MP, et al. Stress characteristics in different work conditions: is it possible to identify specificity of risk factors by the questionnaire method? Eur J Inflamm 2010; 8:117-23.
109. De Berardis D, Conti CMV, Serroni N, et al. The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature. Int J Immunopathol Pharmacol 2010; 23:417-22.
110. Wei QJ, Wei CN, Harada K, Minamoto K, Okamoto Y, Otsuka M, Ueda A. Evaluation of allergenicity of constituents of myoga using the murine local lymph node assay. Int J Immunopathol Pharmacol 2010; 23:463-70.
111. Treating to New Targets Investigators, P. Deedwania, P. Barter and R. Carmena, et al. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets Study. Lancet 2006; 368:919-28.
112. Miraglia Del Giudice M, Pedullà M, Brunese FP, Capristo AF, Capristo C, Tosca MA, Ciprandi G. Neutrophilic cells in sputum of allergic asthmatic children. Eur J Inflamm 2010; 8:151-56.
113. Szkodzinski, B Hudzik J, Romanowski W, Wilczek K, Danikiewicz A, Gasior M, Polonski L, Zubelewicz-Szkodzinska B. Serum concentration of insulin-like growth factor-I, but not tumor necrosis factor-alpha, measured twelve months after stenting of the infarct-related artery, is associated with instent restenosis. J Biol Regul Homeost Agents 2010; 24:149-56.
114. Marchese E, Vignati A, Albanese A, Nucci CG, Sabatino G, Tirpakova B, Lofrese G, Zelano G, Maira G. Comparative evaluation of genome-wide gene expression profiles in ruptured and unruptured human intracranial aneurysms. J Biol Regul Homeost Agents 2010; 24:185-95.